Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.61 |
| ▸ | HPGD | P15428 | 4/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | GLA | P06280 | 1/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.58 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.58 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.57 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1955741 | 0.98 | TRPV1 (0.68) | TRPV1LMNATSHRL3MBTL1HPGD | |
| SCHEMBL1952776 | 0.98 | TRPV1 (0.68) | TRPV1LMNATSHRL3MBTL1HPGD | |
| SCHEMBL1082835 | 0.98 | TRPV1 (0.68) | TRPV1LMNATSHRL3MBTL1HPGD | |
| SCHEMBL1955492 | 0.98 | TRPV1 (0.68) | TRPV1LMNATSHRL3MBTL1HPGD | |
| SCHEMBL1955588 | 0.98 | TRPV1 (0.68) | TRPV1LMNATSHRL3MBTL1HPGD | |
| SCHEMBL1954419 | 0.98 | TRPV1 (0.68) | TRPV1LMNATSHRL3MBTL1HPGD | |
| SCHEMBL1953254 | 0.94 | L3MBTL1 (0.68) | TRPV1TSHRL3MBTL1HPGDALDH1A1 | |
| Hydrochloric Acid SCHEMBL27759637 | 0.93 | L3MBTL1 (0.66) | TRPV1TSHRL3MBTL1HPGDALDH1A1 | |
| SCHEMBL1439724 | 0.86 | CA12 (0.63) | LMNAL3MBTL1HPGDALDH1A1NPC1 | |
| SCHEMBL2019835 | 0.85 | TRPV1 (0.69) | TRPV1LMNATSHRL3MBTL1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190254281-A1 | ENHANCED YIELD IN NUT BEARING PLANTS | UPL CORPORATION LTD. (MU) | 2019-08-22 | — | — | US | claimed |
| EP-2694067-A1 | PYRIDOPYRAZINE DERIVATIVES AND THEIR USE | Æterna Zentaris GmbH (DE) | 2014-02-12 | — | — | EP | claimed |
| WO-2012136691-A1 | PYRIDOPYRAZINE DERIVATIVES AND THEIR USE | ÆTERNA ZENTARIS GMBH (DE) | 2012-10-11 | — | — | WO | claimed |
| WO-2001064036-A1 | ENHANCEMENT OF SEED/FRUIT/NUT YIELDS FROM FLOWERING PLANTS | UNIROYAL CHEMICAL COMPANY, INC. (US) | 2001-09-07 | — | — | WO | claimed |
| US-6242385-B1 | SEEDS OF LEGUME PLANTS, APPLYING TO FOLAGE DURING REPRODUCTION PHENYLUREA DERIVATIVES | UNIROYAL CHEMICAL COMPANY, INC. | 2001-06-05 | — | — | US | claimed |
| US-12409157-B2 | Mitofusin activators and methods of use thereof | DORN, GERALD W., II, DR. | 2025-09-09 | — | — | US | disclosed |
| EP-3527600-B1 | ISOCYANATE COMPOSITION AND PRODUCTION METHOD FOR ISOCYANATE POLYMER | ASAHI CHEMICAL IND (JP) | 2025-07-09 | — | — | EP | disclosed |
| CN-119280245-A | Methods of treating brain tumors using combination therapies | 法国施维雅药厂 | 2025-01-10 | — | — | CN | disclosed |
| EP-4446310-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | Asahi Kasei Kabushiki Kaisha (JP) | 2024-10-16 | — | — | EP | disclosed |
| CN-118382612-A | Method for producing blocked isocyanate compound and method for producing isocyanate compound | 旭化成株式会社 | 2024-07-23 | — | — | CN | disclosed |
| US-20240082180-A1 | MITOFUSIN ACTIVATORS AND METHODS OF USE THEREOF | DORN, GERALD W., II, DR. | 2024-03-14 | — | — | US | disclosed |
| WO-2023106377-A1 | METHOD FOR PRODUCING BLOCKED ISOCYANATE COMPOUND AND METHOD FOR PRODUCING ISOCYANATE COMPOUND | 旭化成株式会社 | 2023-06-15 | — | — | WO | disclosed |
| CN-103553972-A | Method for the preparation of n-substituted carbamic acid ester and method for the preparation of isocyanate using the n-substituted carbamic acid ester | ASAHI KASEI CHEMICALS CORP | 2014-02-05 | — | — | CN | disclosed |
| WO-2012136691-A1 | PYRIDOPYRAZINE DERIVATIVES AND THEIR USE | ÆTERNA ZENTARIS GMBH (DE) | 2012-10-11 | — | — | WO | disclosed |
| CN-102471244-A | Process for producing N-substituted carbamate, process for producing isocyanate using the N-substituted carbamate, and composition for transporting and storing N-substituted carbamate containing N-substituted carbamate and aromatic hydroxy compound | ASAHI KASEI CHEMICALS CORP (JP) | 2012-05-23 | — | — | CN | disclosed |
| US-20110133121-A1 | N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, And Composition For Transfer And Storage Of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound | ASAHI KASEI CHEMICALS CORPORATION (JP) | 2011-06-09 | — | — | US | disclosed |
| WO-2001064036-A1 | ENHANCEMENT OF SEED/FRUIT/NUT YIELDS FROM FLOWERING PLANTS | UNIROYAL CHEMICAL COMPANY, INC. (US) | 2001-09-07 | — | — | WO | disclosed |
| US-6242385-B1 | SEEDS OF LEGUME PLANTS, APPLYING TO FOLAGE DURING REPRODUCTION PHENYLUREA DERIVATIVES | UNIROYAL CHEMICAL COMPANY, INC. | 2001-06-05 | — | — | US | disclosed |
| US-5942536-A | USEFUL FOR TREATING MIGRAINE | ELI LILLY AND COMPANY (US) | 1999-08-24 | — | — | US | disclosed |
| US-5792763-A | MIGRAINES; ANALGESICS; DISEASES LINKED TO DECREASED NEUROTRANMISSION OF SEROTONIN IN MAMMALS | ELI LILLY AND COMPANY (US) | 1998-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240082180-A1 | MITOFUSIN ACTIVATORS AND METHODS OF USE THEREOF | MFN2, FIS1, TFB2M | TRPV1 4276/4885LMNA 859/4885TSHR 4543/4885 |
| US-20110133121-A1 | N-Substituted Carbamic Acid Ester Production Method, Isocyanate Production Method Using Such N-Substituted Carbamic Acid Ester, And Composition For Transfer And Storage Of N-Substituted Carbamic Acid Ester Comprising N-Substituted Carbamic Acid Ester and Aromatic Hydroxy Compound | CPS1, ALKBH3, RCC1 | TRPV1 3766/4885LMNA 1776/4885TSHR 4686/4885 |
| US-20190254281-A1 | ENHANCED YIELD IN NUT BEARING PLANTS | NUTF2, MYCBP, MYCBP2 | TRPV1 4690/4885LMNA 3523/4885TSHR 4611/4885 |
| US-12409157-B2 | Mitofusin activators and methods of use thereof | MFN2, FIS1, TFB2M | TRPV1 4276/4885LMNA 859/4885TSHR 4543/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.